Clinical Trials on Parenteral Nutrition Associated Liver Disease (PNALD) in Sweden
Total 31 results
-
Ali AminianNot yet recruitingObesity | Liver Fibrosis | Non-Alcoholic Fatty Liver Disease | Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) | Metabolic Dysfunction-Associated Steatohepatitis (MASH)United States, Sweden, Ireland, Finland, United Kingdom, Spain, Switzerland, Brazil, Canada, Italy, Kuwait, India, Mexico
-
Region Örebro CountyUnknownObesity | Weight Loss | Non-Alcoholic Fatty Liver DiseaseSweden
-
Hanns-Ulrich MarschallCompletedNon-alcoholic Fatty Liver DiseaseSweden
-
Helsinki University Central HospitalGöteborg University; Sahlgrenska University Hospital, SwedenCompleted
-
Region SkaneThe Swedish Research Council for Environment, Agricultural Sciences and Spatial...Terminated
-
Göteborg UniversityKarolinska University Hospital; Lund University; Sahlgrenska University Hospital...Active, not recruitingInflammation | Hypertension | Obesity | Diabetes | SteatohepatitisSweden
-
Göteborg UniversityVastra Gotaland RegionRecruitingFibrosis | Inflammation | Obesity | Metabolic Syndrome | Liver Disease | Kidney Disease | Cardiometabolic SyndromeSweden
-
AstraZenecaUppsala Clinical Research, Uppsala, SwedenCompletedT2 Diabetes and Fatty Liver Disease (Non-alcoholic Origin)Sweden
-
AstraZenecaCompletedHypertriglyceridemia | Non-alcoholic Fatty Liver Disease (NAFLDSweden
-
Marja-Riitta TaskinenGöteborg UniversityEnrolling by invitationInsulin Resistance | Non-alcoholic Fatty Liver | Atherogenic DyslipidemiaFinland, Sweden
-
MetaboGen ABGöteborg UniversityRecruitingImpaired Glucose Tolerance | Pre Diabetes | Non-Alcoholic Fatty Liver DiseaseSweden
-
Karolinska University HospitalEnrolling by invitationObesity | Dyslipidemia | Non-alcoholic Fatty Liver Disease | Diabetes Mellitus Type 2Sweden
-
Uppsala UniversitySwedish Council for Working Life and Social ResearchCompletedObesity | Diabetes | Fatty Liver | Insulin ResistanceSweden
-
AstraZenecaRecruitingNon-alcoholic Steatohepatitis (NASH)Austria, Germany, Japan, Sweden
-
Newcastle UniversityAssistance Publique - Hôpitaux de Paris; Medical University of Vienna; University... and other collaboratorsRecruitingCardiovascular Diseases | Hypertension | Obesity | Hepatocellular Carcinoma | Type 2 Diabetes | NAFLD | Fibrosis, Liver | NASH - Nonalcoholic Steatohepatitis | Dyslipidaemia | NASH | Steatosis of Liver | Other Associated ComorbiditiesNetherlands, Germany, United Kingdom, Finland, Belgium, Greece, Italy, Sweden, Portugal, Spain, France, Switzerland
-
AstraZenecaCompletedBleeding ,Arrhythmias, Heart Failure, Acute Renal Failure, Acute Liver Failure, Dyspnoea, GoutSweden
-
Linkoeping UniversityAmra Medical ABRecruitingLiver Cirrhosis | Hepatocellular Carcinoma | Sarcopenia | Portal HypertensionSweden
-
Helse Stavanger HFKing's College London; Lund UniversityCompletedDementia With Lewy Bodies | Dementia Associated With Parkinson's DiseaseUnited Kingdom, Norway, Sweden
-
Alnylam PharmaceuticalsCompletedPorphyria, Acute Intermittent | Acute Intermittent Porphyria (AIP) | Acute Hepatic Porphyria (AHP) | Acute PorphyriaSweden
-
Swedish Institute for Infectious Disease ControlUnknownHepatitis B | Measles | Pertussis | Rubella | Mumps | Tetanus | Diphtheria | Polio | Haemophilus Influenzae Type BSweden
-
Alnylam PharmaceuticalsCompletedAcute Intermittent PorphyriaUnited States, United Kingdom, Sweden
-
Alnylam PharmaceuticalsCompletedAcute Intermittent PorphyriaUnited States, United Kingdom, Sweden
-
GlaxoSmithKlineCompletedHepatitis B | Tetanus | Diphtheria | Acellular Pertussis | Poliomyelitis | Haemophilus Influenzae Type b | Diphtheria-Tetanus-aPertussis-Poliomyelitis-Haemophilus Influenzae Type b VaccinesSweden, Norway
-
BiogenRecruitingAmyotrophic Lateral Sclerosis Associated With a SOD1 Gene MutationUnited States, Canada, Spain, Australia, Germany, Italy, Japan, Korea, Republic of, United Kingdom, Belgium, Brazil, France, Poland, Sweden
-
GlaxoSmithKlineCompletedHepatitis B | Tetanus | Diphtheria | Acellular Pertussis | Poliomyelitis | Haemophilus Influenzae Type bItaly, Sweden, Finland
-
Alnylam PharmaceuticalsRecruitingAcute Hepatic PorphyriaBelgium, France, Germany, United Kingdom, United States, Italy, Switzerland, Sweden
-
Mitsubishi Tanabe Pharma America Inc.Active, not recruitingEPP | XLPUnited States, Germany, Japan, Spain, Italy, Sweden, Australia, Canada, Norway, United Kingdom
-
Mitsubishi Tanabe Pharma America Inc.CompletedEPP | XLPSpain, United States, Germany, Norway, Italy, Australia, Canada, Japan, Sweden, United Kingdom
-
Rigshospitalet, DenmarkUniversity College, LondonEnrolling by invitationEnd Stage Liver Disease | Cardiovascular Diseases | Fractures, Bone | Diabetes Mellitus | Renal Insufficiency | Hepatitis B | Hepatitis C | Kidney Failure, Chronic | Proteinuria | HIV | Coinfection | Acidosis, Lactic | AIDSSpain, Switzerland, Germany, United Kingdom, Austria, Sweden, Finland, Israel, Denmark, France, Italy, Iceland, Belgium, Slovakia, Norway, Lithuania, Portugal, Poland, Croatia, Czechia, Greece, Hungary, Luxembourg, Argentina, Belarus, Bosnia... and more
-
Alnylam PharmaceuticalsCompletedAcute Hepatic Porphyria | Acute Intermittent Porphyria | Porphyria, Acute Intermittent | Acute Porphyria | Hereditary Coproporphyria (HCP) | Variegate Porphyria (VP) | ALA Dehydratase Deficient Porphyria (ADP)United States, Spain, United Kingdom, Korea, Republic of, Australia, Bulgaria, Canada, Denmark, Finland, France, Germany, Italy, Japan, Mexico, Netherlands, Poland, Sweden, Taiwan